what is missing in this slide?

Reading File
Running Command
Running Command
Running Command
Finding Files
Running Command
analyse_media
analyse_media
analyse_media
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have a thorough view of all 62 slides. Let me do a careful analysis of what's missing across this CSCR Part 1 presentation.
Here is a detailed breakdown of what is missing from this presentation on Central Serous Chorioretinopathy (CSCR) & Pachychoroid Spectrum Disorder:

Content Gaps

1. Slide 1 - Title Slide is Bare

The title slide has no subtitle information such as author/presenter name, institution, date, or course/module context. These are standard for a medical education deck.

2. Slide 10 - Multimodal Imaging (PPE)

This slide only has text bullets. It is missing representative OCT/ICGA/FAF images to visually demonstrate the findings described (sub-RPE deposits, reduced CC flow density, mottled hypofluorescence). For an imaging-heavy disease like PPE, this is a significant gap.

3. Slide 31 - OCT Findings Acute CSCR

There is a small OCT schematic diagram present, but no actual OCT scan image of acute CSCR. Real OCT images (showing SRF, dome-shaped PED, IS/OS disruption) are the standard of teaching here and are absent.

4. Slide 34 - FA "Ink Blot" Pattern

The slide describes the FA ink blot pattern in text only - no fluorescein angiography image is included. This is the most characteristic FA finding in CSCR and a visual is essential.

5. Slide 35 - FA "Smoke Stack" Pattern

Same issue - the smoke stack pattern is described in words but no FA image or video frame is shown. This pattern is visually dramatic and almost impossible to appreciate without a picture.

6. Slide 36 - ICGA

No ICGA image is included. ICGA is described as the gold standard for choroidal imaging in CSCR, yet there is no representative image showing pachyvessel hyperpermeability.

7. Slide 37 - FAF

No FAF image to illustrate the gravitational tract, hyper/hypofluorescent patterns described.

8. Slide 39 - Differential Diagnosis Table

The differential diagnosis table exists but is missing VKH (Vogt-Koyanagi-Harada) in the bottom-right cell - the column header appears but the cell content for VKH features is absent or very sparse. Also absent from the differential: uveal effusion syndrome, optic pit maculopathy, and rhegmatogenous RD (important differentials in clinical practice).

9. Slide 40 - Management Acute CSCR Flowchart

The flowchart mentions "focal laser (leakage away from fovea)" and "micropulse laser" as options but does not include eplerenone/MRA as an early treatment option for acute cases, which is supported by some evidence.

10. Slide 41 - Management Chronic CSCR

The flowchart is present but the "Options (limited evidence)" box for "No SRF on OCT" branch is partially cut off/unclear, and the transition criteria between branches (e.g., what defines "persistent SRF") could be clearer. Also missing: treatment algorithm for CSCR in pregnancy (linking back to slide 24).

11. Slide 44 - Micropulse Laser & Anti-VEGF

Anti-VEGF section correctly states it is not first-line, but no mention of ranibizumab in the anti-VEGF section despite it having RCT data (VICI trial uses eplerenone; ranibizumab data exists for the CNV component). Also missing: dosing protocols for micropulse laser.

12. Slide 48 - PCV Imaging

An OCT image is shown on the right, but no ICGA image is included - yet ICGA is explicitly stated as the gold standard for PCV diagnosis (slide 47). The polypoidal lesions that define PCV are best seen on ICGA.

13. Slide 62 - Summary Slide

The summary slide covers only 6 key points. It is missing a summary of the full pachychoroid spectrum (PCV, PNV, PPS, FCE entities are not summarized). It also lacks a "take home message" regarding when to refer or urgency, and there are no references/bibliography for the major trials cited (VICI, EVEREST II, PLANET, Cochrane NMA 2025).

Structural / Organizational Gaps

GapDetails
No learning objectives slideNo slide states what the learner should know by the end of Part 1
No references / bibliography slide20+ trials and papers are cited inline but there is no consolidated reference list
No clinical images throughoutDespite describing a visually-diagnosed disease, clinical fundus photos, OCT scans, FA/ICGA images are almost entirely absent from most slides
No "Part 1 vs Part 2" scope slideUsers don't know what's covered in Part 2 vs Part 1
No MCQ/self-assessment slideCommon in educational decks to reinforce learning
Slide 17 (Risk Factors - Systemic)H. pylori listed but the evidence is described as "controversial" - the slide could clarify current consensus more explicitly

Summary of the Most Critical Omissions

  1. Clinical images (OCT, FA, ICGA, FAF) are almost entirely absent - this is a major gap for a visual specialty like ophthalmology
  2. No learning objectives at the start
  3. No references slide at the end
  4. Slide 62 summary is incomplete - doesn't cover the full pachychoroid spectrum entities
  5. Management slides are missing eplerenone as an acute option and lack a pregnancy-specific treatment algorithm

i will add the clinical images but add others what are missing

Reading File
Reading File
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
Reading File
Running Command
Writing File
Running Command
Running Command
Running Command
Finding Files
Finding Files
Reading File
All 8 new slides look clean and match the original deck's style (navy blue header bar, clean white body, matching font/color scheme). Here's your supplementary file:

CSCR NewSlides Supplement

Presentation · PPTX


What Was Added (8 new slides)

SlideTitleWhere to insert
1Learning Objectives (10 numbered objectives)After title slide (slide 1)
2Scope - Part 1 vs Part 2 (two-column layout)After learning objectives
3CSCR in Pregnancy - Treatment Algorithm (flowchart: mild vs severe pathway, DDx warning for pre-eclampsia)After existing slide 24
4Differential Diagnosis - Expanded Table (7 conditions with imaging clue + management pointer, including VKH, uveal effusion, RRD)Replaces/supplements existing slide 39
5Pachychoroid Spectrum - Unified Summary Table (all 6 entities with abbreviation, key feature, CNV status, treatment)After existing slide 8 (spectrum slide)
6References & Key Literature (5 sections: pathogenesis, trials, PDT/treatment, epidemiology, imaging - ~15 citations)Final slide
7Self-Assessment MCQs Part A (4 clinical scenarios)Before references
8MCQ Answers & Explanations (detailed answer rationale for all 4 questions)After MCQ slide

How to merge: Open both files in PowerPoint, select all slides in this supplement (Ctrl+A in slide panel), copy, then paste into your main deck at the desired positions.

is focal choroidal excavation a part of pachchoroid disease

Finding Sources
Searching PubMed

"focal choroidal excavation" AND pachychoroid

Reading Article
Reading Article
Searching PubMed

"focal choroidal excavation" pathogenesis classification

Reading Article
Reading Article
This is a nuanced and genuinely unsettled question. Here's the full picture:

Is FCE Part of the Pachychoroid Spectrum? - Short Answer: Contested - Partially Yes, With Major Caveats


Why It Was Included in the Spectrum

Spaide and colleagues originally proposed FCE as a pachychoroid entity based on the observation that:
  • Some FCE cases show thick choroid with dilated Haller layer veins (pachyvessels) on OCT
  • FCE frequently co-exists with CSCR and PNV - two established pachychoroid entities
  • The focal RPE-CC-choriocapillaris bowing in FCE could reflect focal pachychoroid mechanical stress at the RPE-Bruch's interface
This is why it appears in the "6-entity" pachychoroid spectrum list that your slide 8 uses (PPE → CSCR → PNV → PCV → PPS → FCE).

Why It's Now Considered Differently

The key problem is that FCE is fundamentally a morphological/OCT descriptor, not a distinct disease with a unified pathogenesis:
FCE TypeChoroidal ThicknessPachychoroid Features?Associated With
Type 1 - Myopic<100 µm (thin)NoHigh myopia
Type 2 - Congenital100-200 µm (normal)NoUsually isolated, benign
Type 3 - Acquired/Secondary>200 µm (thick)Yes (47%)CSCR, pachyvessels, CNV
  • Capellan et al. BJO 2023 classified FCE into 3 subtypes - only Type 3 (V-shaped, acquired, thick choroid) is associated with CSCR/pachyvessels
  • Lei et al. Survey Ophthalmol 2025 (the most recent review) explicitly states: "its pathogenesis is currently not completely understood" and emphasizes that FCE can exist alone OR secondary to other chorioretinopathies - suggesting it is a morphological finding rather than a primary pachychoroid disease
  • Brown, Mohan & Chhablani (J Ophthalmic Vis Res 2023) - which is one of the most comprehensive updated reviews - does include FCE in the pachychoroid spectrum, but explicitly calls for a consistent classification scheme to be established, acknowledging the current inconsistency

The Critical Distinction

FCE is more accurately a morphological OCT sign that can occur in the context of pachychoroid disease - but is not exclusively or primarily a pachychoroid entity.
Compare it to the others:
  • PPE, CSCR, PNV, PCV, PPS all have pachychoroid as a necessary and primary feature
  • FCE can occur with a thin choroid (myopic), normal choroid (congenital), or thick choroid (pachychoroid-related) - pachychoroid is therefore neither necessary nor sufficient for FCE

What Your Slide Should Say

Your slide 53 (FCE slide) actually gets this right - it says:
"May co-exist with CSCR or PNV - role in pathogenesis still under investigation" "No established treatment - monitor with serial OCT; treat associated CSCR or PNV if present"
This is the correct framing. FCE should be presented as:
  • An associated/incidental OCT morphological finding that overlaps with the pachychoroid spectrum in a subset of cases (specifically Type 3, V-shaped, acquired FCE)
  • Not a primary pachychoroid disease in the same mechanistic sense as CSCR or PCV
  • Included in the spectrum for descriptive/classification completeness, but with the caveat that its inclusion is debated

Bottom Line for Your Presentation

I'd recommend adding a footnote or asterisk to FCE on slide 8 (the pachychoroid spectrum slide) noting:
"FCE: included in spectrum as a descriptive entity; pathogenesis distinct from other entities - may be congenital, myopic, or pachychoroid-associated (Type 3 only)"
This reflects the current 2023-2025 literature accurately and preempts the very question you just asked if this is being used for teaching.

from where do i add the clinical picture of FCE

Good practical question. Here are your best sources for free, citable FCE clinical images:

1. PubMed Central (PMC) - Open Access Papers

The best single source. These papers have FCE OCT images you can use with attribution:

2. Retina Image Bank (retinaimagegallery.net / imagingretina.com)

  • Run by the American Society of Retina Specialists (ASRS)
  • Free to use for educational, non-commercial purposes with attribution
  • Search: "focal choroidal excavation"

3. EyeRounds (University of Iowa)

  • High-quality clinical images with detailed case descriptions
  • Explicitly free for medical education
Search: "choroidal excavation"

4. Ophthalmology Image Resources (OphSys / OSLI Retina)

  • OSLI Retina journal has open-access case reports with FCE OCT images
  • Search Google Scholar: "focal choroidal excavation" site:journals.healio.com

5. Your Own Institutional Cases

If you have access to a retina unit OCT database, this is the cleanest option - de-identified patient OCTs from your own institution require no copyright clearance and are the most authentic for teaching.

What Images to Look For Specifically

For a complete FCE slide you want:
ImageWhat It Shows
Conforming FCE (U-shaped)RPE dips into excavation; photoreceptors follow - usually congenital/benign
Non-conforming FCE (V-shaped)RPE dips but photoreceptors do NOT follow - gap between RPE and IS/OS - associated with CSCR/pachychoroid
OCTA of FCEFlow signal within the excavation (if CNV present)
Before/after comparisonShows stability over time (key teaching point)
FCE + CSCR co-existingSRF above the excavation site - illustrates the pachychoroid link

Copyright Reminder

When using any external image in a teaching slide, add a caption like:
"Adapted from [Author et al., Journal Year], licensed under CC BY / used with permission"
PMC open-access articles (CC BY licence) are the safest bet for presentations that may be shared broadly.

NOW I HAVE ADDED THE MISSING PARTS. WHAT ARE THE GAPS IN THE SLIDE? HELP ME STUDY THE TOPIC AND PRESENT WELL, STEP BY STEP

Running Command
Finding Files
Running Command
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File

OVERALL VERDICT ON THE DECK

The deck is now very strong. The remaining gaps are mostly minor content additions rather than structural holes:
Top 3 priority fixes before presenting:
  1. Slide 57 - add contraindications to eplerenone/spironolactone (you will be asked)
  2. Slide 32 - add EDI/SS-OCT note for choroidal thickness measurement
  3. Slide 66 (References) - expand beyond 4 textbooks to include the primary journals; it looks incomplete to an examiner
What is excellent and ready:
  • Clinical images are now in the key slides (FA patterns, ICGA, FAF, PPS, FCE, PCV)
  • Learning objectives slide sets the scope clearly
  • Differential diagnosis expanded table (slide 41) is very well done
  • All 6 trial slides (VICI, EVEREST II, PLANET, Cochrane, APEX, van Dijk) are present
  • Pregnancy management algorithm is included
  • Spectrum summary table (slide 65) is a strong closing reference
Tell me which module you want to drill first and I'll quiz you on it.
This is a shared conversation. Sign in to Orris to start your own chat.